said AstraZeneca Executive Vice President of Oncology David Fredrickson. The U.S. Food and Drug Administration first approved the drug in 2017 to treat a type of bladder cancer. Imfinzi won ...

David Fredrickson, executive vice president of AstraZeneca's oncology business unit (AstraZeneca) There are still more data to come. While the trial has so far shown a “numerically favorable ...

David has helped thousands of clients improve their accounting and financial systems, create budgets, and minimize their taxes. JONATHAN NACKSTRAND / Contributor / Getty Images AstraZeneca said on ...

That’s the question posed by the 4% fall in AstraZeneca’s (AZN.L), opens new ... president of oncology research and development, or David Fredrickson, who runs the commercial strategy for ...

Following a pipeline review of AstraZeneca’s AZN late-stage pipeline, we are increasing the long-term projections for several drugs, including camizestrant (breast cancer), capivasertib (breast ...